Tags

Type your tag names separated by a space and hit enter

Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment.
J Am Acad Dermatol. 2014 Nov; 71(5):859.e1-859.e15; quiz 873-4.JA

Abstract

Dermatologists are in a key position to treat the manifestations of polycystic ovary syndrome (PCOS). The management of PCOS should be tailored to each woman's specific goals, reproductive interests, and particular constellation of symptoms. Therefore, a multidisciplinary approach is recommended. In part II of this continuing medical education article, we present the available safety and efficacy data regarding treatments for women with acne, hirsutism, and androgenetic alopecia. Therapies discussed include lifestyle modification, topical therapies, combined oral contraceptives, antiandrogen agents, and insulin-sensitizing drugs. Treatment recommendations are made based on the current available evidence.

Authors+Show Affiliations

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.Department of Dermatology, Harvard Medical School, Boston, Massachusetts.Department of Dermatology, Tufts University School of Medicine, Boston, Massachusetts.Department of Dermatology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: rreynold@bidmc.harvard.edu.

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

25437978

Citation

Buzney, Elizabeth, et al. "Polycystic Ovary Syndrome: a Review for Dermatologists: Part II. Treatment." Journal of the American Academy of Dermatology, vol. 71, no. 5, 2014, pp. 859.e1-859.e15; quiz 873-4.
Buzney E, Sheu J, Buzney C, et al. Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment. J Am Acad Dermatol. 2014;71(5):859.e1-859.e15; quiz 873-4.
Buzney, E., Sheu, J., Buzney, C., & Reynolds, R. V. (2014). Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment. Journal of the American Academy of Dermatology, 71(5), e1-e15; quiz 873-4. https://doi.org/10.1016/j.jaad.2014.05.009
Buzney E, et al. Polycystic Ovary Syndrome: a Review for Dermatologists: Part II. Treatment. J Am Acad Dermatol. 2014;71(5):859.e1-859.e15; quiz 873-4. PubMed PMID: 25437978.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Polycystic ovary syndrome: a review for dermatologists: Part II. Treatment. AU - Buzney,Elizabeth, AU - Sheu,Johanna, AU - Buzney,Catherine, AU - Reynolds,Rachel V, Y1 - 2014/10/15/ PY - 2014/02/23/received PY - 2014/05/05/revised PY - 2014/05/05/accepted PY - 2014/12/2/entrez PY - 2014/12/2/pubmed PY - 2015/1/22/medline KW - acne KW - androgenetic alopecia KW - combined oral contraceptive pills KW - cyproterone acetate KW - drospirenone KW - hirsutism KW - insulin-sensitizing drugs KW - polycystic ovary syndrome KW - spironolactone SP - 859.e1-859.e15; quiz 873-4 JF - Journal of the American Academy of Dermatology JO - J Am Acad Dermatol VL - 71 IS - 5 N2 - Dermatologists are in a key position to treat the manifestations of polycystic ovary syndrome (PCOS). The management of PCOS should be tailored to each woman's specific goals, reproductive interests, and particular constellation of symptoms. Therefore, a multidisciplinary approach is recommended. In part II of this continuing medical education article, we present the available safety and efficacy data regarding treatments for women with acne, hirsutism, and androgenetic alopecia. Therapies discussed include lifestyle modification, topical therapies, combined oral contraceptives, antiandrogen agents, and insulin-sensitizing drugs. Treatment recommendations are made based on the current available evidence. SN - 1097-6787 UR - https://www.unboundmedicine.com/medline/citation/25437978/Polycystic_ovary_syndrome:_a_review_for_dermatologists:_Part_II__Treatment_ DB - PRIME DP - Unbound Medicine ER -